$XTNT INSIDE PITCHFORK$XTNT INSIDE PITCHFORK
Wyckoff Re-accumulation after decline, Strong Volume building
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
XTNT trade ideas
$XTNTXtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
XTNT: Bullish PennantBullish Pennant
Pros:
Post forming with volume
Descending volume during Pennant forming
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 5
250RSI above 50
Cons:
200MA flat
Target:
PT = 7.00$
1000 Followers! Thank you all!
Thank you to those who donate Coins!
Stay Humble, have fun, make money!
Why $XTNT stock skyrocketed on friday?Xtant Medical Comments on Trading Activity of its Stock
$XTNT announced on friday that it is not aware of any material, undisclosed corporate developments or material change in its business or affairs that has not been publicly disclosed that would account for the recent increase in the market price or trading volume of its shares.
Reason of the increase on friday is likely traders in private chats pumping up shares of the stock. Social media talk seems to suggest as much. This has been a growing trend in recent months with twitter, stocktwits dedicated to pumping and dumping stocks.
it’s hard to pin down where exactly the push into CLEU stock came from. However, once news of the pump spreads to larger social media it typically creates interest in stocks as other investors jump on the bandwagon looking for profits.
XTNT Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE
$XTNT - Xtant Medical Holdings, Inc. Common Stock
Initial Alert Price: $1.29
Price High: $6.58
% Gains/Losses: 410.08%
(+386% More Than Expected)
Potential Stop Loss: $6.251
XTNT broke out to $6.58 providing a 410% Return on our Initial Alert on January 5th, 2021 after the OrbiMed announced a 94.8% Stake in the company. Scalping profits on a breakout such as this one will encourage one to conduct our Split and Run Tactic of closing half of position to secure initial investment risks while allowing profits to continue collecting profits as XTNT is showing signs of falling into a continuation pattern after consolidating to the $5.50 Price Levels. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
XTNT SwingI like this chart. The MACD is crossing and yesterday there was a small gap up to open. I like the multiple bottom in early November around the $1.10 range which established support. I would like to see it break $1.42 to enter for a swing.
$1.62 first target
$1.79 second target
WWW.Weedkiller420.com